Biomarkers for diagnosis and monitoring of celiac disease

Journal of Clinical Gastroenterology

Volumn 47, Issue 4, 2013, Pages 308-313

  Vives Pi, Marta ^a   Takasawa, Shin ^b   Pujol Autonell, Irma ^a   Planas, Raquel ^a   Cabre, Eduard ^c   Ojanguren, Isabel ^c   Montraveta, Montserrat ^d   Santos, Agustin L ^a   Ruiz Ortiz, Estíbaliz ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Autoimmunity; Biomarkers; Celiac disease; Small intestine

Indexed keywords

ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEAMINATED ANTIBODY; ENDOMYSIUM ANTIBODY; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 12P35; INTERLEUKIN 18R1; INTERLEUKIN 18RAP; INTERLEUKIN 2; INTERLEUKIN 21; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; REG 1ALPHA ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CELIAC DISEASE; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENE LOCUS; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INTESTINE BIOPSY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROLOGY; ULCERATIVE COLITIS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; CELIAC DISEASE; DIET, GLUTEN-FREE; GENETIC MARKERS; HLA-DQ ANTIGENS; HUMANS; LITHOSTATHINE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84875382697     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31827874e3     Document Type: Review

References (44)

1. Rubio-Tapia A, Murray JA. Coeliac disease. Curr Opin Gastroenterol. 2010;26:116-122
2. Mubarak A, Houwen RH, Wolters VM. Celiac disease: An overview from pathophysiology to treatment. Minerva Pediatr. 2012;64:271-287
3. Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol. 2012;34:473-478
4. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88-93
5. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol. 2009;9:858-870
6. Lahdenperä AI, Hölttä V, Ruohtula T, et al. Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes. Clin Exp Immunol. 2012;167:226-234
7. Rodrigo L. Celiac disease. World J Gastroenterol. 2006;12: 6585-6593
8. Rubio-Tapia A, Rahim MW, See JA, et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol. 2010;105:1412-1420
9. Silano M, Agostoni C, Guandalini S. Effect of the timing of gluten introduction on the development of celiac disease. World J Gastroenterol. 2010;16:939-942
10. Sellitto M, Bai G, Serena G, et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One. 2012;7:e33387
11. Heyman M, Abed J, Lebreton C, et al. Intestinal permeability in coeliac disease: Insight into mechanisms and relevance to pathogenesis. Gut. 2012;61:1355-1364
12. Meresse B, Ripoche J, Heyman M, et al. Celiac disease: From oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol. 2009;2:8-23
13. Husby S, Koletzko S, Korponay-Szabó IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136-160
14. Monzani A, Rapa A, Fonio P, et al. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease. J Pediatr Gastroenterol Nutr. 2011;53:55-60
15. Planas R, Pujol-Autonell I, Ruiz E, et al. Regenerating gene Ia is a biomarker for diagnostic and monitoring of celiac disease: A preliminary study. Transl Res. 2011;158:140-145
16. Trynka G, Wijmenga C, van Heel DA. A genetic perspective on coeliac disease. Trends Mol Med. 2010;16:537-550
17. Gutierrez-Achury J, Coutinho de Almeida R, Wijmenga C. Shared genetics in coeliac disease and other immune-mediated diseases. J Intern Med. 2011;269:591-603
18. Vermeulen BA, Hogen Esch CE, Yuksel Z, et al. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol. 2009;44:40-45
19. Ferrara F, Quaglia S, Caputo I, et al. Anti-Transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin Exp Immunol. 2010;159:217-223
20. Stenberg R, Dahle C, Lindberg E, et al. Increased prevalence of anti-gliadin antibodies and anti-Tissue transglutaminase antibodies in children with cerebral palsy. J Pediatr Gastroenterol Nutr. 2009;49:424-429
21. Alaedini A, Green PH. Autoantibodies in celiac disease. Autoimmunity. 2008;41:19-26
22. Preisz K, Sardy M, Horvath A, et al. Immunoglobulin complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2005;19:74-79
23. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med. 2008;205:143-154
24. Brottveit M, Rá ki M, Bergseng E, et al. Assessing possible celiac disease by an HLA-DQ2-gliadin tetramer test. Am J Gastroenterol. 2011;106:1318-1324
25. Terazono K, Yamamoto H, Takasawa S, et al. A novel gene activated in regenerating islets. J Biol Chem. 1988;263: 2111-2114
26. Acquatella-Tran Van Ba I, Marchal S, François F, et al. Regenerating islet-derived 1a (Reg-1a) protein is new neuronal secreted factor that stimulates neurite outgrowth via exostosin Tumor-like 3 (EXTL3) receptor. J Biol Chem. 2012;287: 4726-4739
27. Zhang YW, Ding LS, Lai MD. Reg gene family and human diseases. World J Gastroenterol. 2003;9:2635-2641
28. Ogawa H, Fukushima K, Naito H, et al. Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis. 2003;9:162-170
29. Gurr W, Yavari R, Wen L, et al. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T cell autoantigen in NOD mice. Diabetes. 2002;51:339-346
30. Watanabe T, Yonekura H, Terazono K, et al. Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem. 1990;265: 7432-7439
31. Shervani NJ, Takasawa S, Uchigata Y, et al. Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients. Eur J Clin Invest. 2004;34:752-758
32. Planas R, Alba A, Carrillo J, et al. Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: Role of IFNb. Diabetología. 2006;49: 2379-2387
33. Kimura T, Fukui H, Sekikawa A, et al. Involvement of REG Ia protein in the regeneration of ductal epithelial cells in the minor salivary glands of patients with Sjögren's syndrome. Clin Exp Immunol. 2009;155:16-20
34. Watanabe T, Yonemura Y, Yonekura H, et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA. 1994;91: 3589-3592
35. Gross DJ, Weiss L, Reibstein I, et al. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide induced immunoregulation combined with Reg protein treatment. Endocrinology. 1998;139:2369-2374
36. Unno M, Nata K, Noguchi N, et al. Production and characterisation of Reg knockout mice: Reduced proliferation of pancreatic b-cells in Reg knockout mice. Diabetes. 2002;51(suppl 3):S478-S483
37. Planas R, Carrillo J, Sanchez A, et al. Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: New findings at clinical onset and in longstanding diabetes. Clin Exp Immunol. 2010;159:23-44
38. Astorri E, Guglielmi C, Bombardieri M, et al. Circulating Reg1a proteins and autoantibodies to Reg1a proteins as biomarkers of b-cell regeneration and damage in type 1 diabetes. Horm Metab Res. 2010;42:955-960
39. Jonsson R, Vogelsang P, Volchenkov R, et al. The complexity of Sjögren's syndrome: Novel aspects on pathogenesis. Immunol Lett. 2011;141:1-9
40. Ose T, Kadowaki Y, Fukuhara H, et al. Reg I-knockout mice reveal its role in regulation of cell growth that is required in generation and maintenance of the villous structure of small intestine. Oncogene. 2007;26:349-359
41. Sekikawa A, Fukui H, Fujii S, et al. REG Ia protein mediates an anti-Apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis. 2008;29:76-83
42. McMillan SA, Dickey W, Douglas JP, et al. Transthyretin values correlate with mucosal recovery in patients with coeliac disease taking a gluten free diet. J Clin Pathol. 2001;54:783-786
43. Martí n-Pagola A, Ortiz-Paranza L, Bilbao JR, et al. Two-year follow-up of anti-Transglutaminase autoantibodies among celiac children on gluten-free diet: Comparison of IgG and IgA. Autoimmunity. 2007;40:117-121
44. Wedgwood JF, Palmer R, Weinberger B. Development of the ability to make IgG and IgA in newborns and infants. Mt Sinai J Med. 1994;61:409-415